Conjugated equine estrogen treatment corrected the exacerbated aorta oxidative stress in ovariectomized spontaneously hypertensive rats

Steroids

Volumn 78, Issue 3, 2013, Pages 341-346

  Ceravolo, Graziela S ^a,b   Filgueira, Fernando P ^a   Costa, Tiago J ^a   Lobato, Nubia S ^a,c   Chignalia, Andréia Z ^a   Araujo, Priscila X ^a   Tostes, Rita C ^a   Dantas, Ana P ^d   Fortes, Zuleica B ^a   Carvalho, Maria Helena C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

^c FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Conjugated equine estrogens; Hypertension; Ovariectomyzed rats; Vascular reactivity

Indexed keywords

CATALASE; CONJUGATED ESTROGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; AORTA; CATALASE; ENDOTHELIUM, VASCULAR; ESTROGENS, CONJUGATED (USP); FEMALE; GENE EXPRESSION; HORSES; HUMANS; HYPERTENSION; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TISSUE CULTURE TECHNIQUES;

EQUIDAE; RATTUS;

EID: 84873034344     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.11.018     Document Type: Article

References (41)

1. N. Engberding, and N.K. Wenger Management of hypertension in women Hypertens Res 35 2012 251 260
2. M.E. Mendelsohn, and R.H. Karas HRT and the young at heart N Engl J Med 356 2007 2639 2641
3. M.E. Mendelsohn Protective effects of estrogen on the cardiovascular system Am J Cardiol 89 2002 12E 17E
4. D. Grady, D. Herrington, and V. Bittner Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS II) JAMA 288 2002 49 57
5. M. Stramba-Badiale, K.M. Fox, and S.G. Priori Cardiovascular diseases in women: a statement from the policy conference of the European society of cardiology Eur Heart J 27 2006 994 1005
6. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group JAMA 280 1998 605 613
7. D. Grady, W. Applegate, T. Bush, C. Furberg, B. Riggs, and S.B. Hulley Heart and estrogen/progestin replacement study (HERS): design, methods, and baseline characteristics Control Clin Trials 19 1998 314 335
8. J. Hsia, R.D. Langer, and J.E. Manson Conjugated equine estrogens and coronary heart disease: the women's health initiative Arch Intern Med 166 2006 357 365
9. M.S. Ozers, K.M. Ervin, and C.L. Steffen Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization Mol Endocrinol 19 2005 25 34
10. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
11. E. Falkenstein, H.C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple actions of steroid hormones-a focus on rapid, nongenomic effects Pharmacol Rev 52 2000 513 556
12. R.S. Davies, R.K. Vohra, A.W. Bradbury, and D.J. Adam The impact of hormone replacement therapy on the pathophysiology of peripheral arterial disease Eur J Vasc Endovasc Surg 34 2007 569 575
13. V.M. Miller, and S.P. Duckles Vascular actions of estrogens: functional implications Pharmacol Rev 60 2008 210 241
14. A.P. Dantas, C. Franco Mdo, and R.C. Tostes Relative contribution of estrogen withdrawal and gonadotropins increase secondary to ovariectomy on prostaglandin generation in mesenteric microvessels J Cardiovasc Pharmacol 43 2004 48 55
15. N. Kikuchi, M. Urabe, and K. Iwasa Atheroprotective effect of estriol and estrone sulfate on human vascular smooth muscle cells J Steroid Biochem Mol Biol 72 2000 71 78
16. G.S. Ceravolo, L. Fernandes, and C.D. Munhoz Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats Hypertension 50 2007 756 761
17. L.R. Faust, J. el Benna, B.M. Babior, and S.J. Chanock The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis J Clin Invest 96 1995 1499 1505
18. Q. Zeng, Y. Han, and Y. Bao 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+ channel via a PKC-dependent mechanism in cardiomyocytes Am J Physiol Heart Circ Physiol 299 2010 H1109 1117
19. D.C. Fernandes, J. Wosniak Jr., and L.A. Pescatore Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems Am J Physiol Cell Physiol 292 2007 C413 422
20. M.H. Carvalho, R. Scivoletto, Z.B. Fortes, D. Nigro, and S. Cordellini Reactivity of aorta and mesenteric microvessels to drugs in spontaneously hypertensive rats: role of the endothelium J Hypertens 5 1987 377 382
21. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 2007 245 313
22. A.P. Dantas, R. Scivoletto, Z.B. Fortes, D. Nigro, and M.H. Carvalho Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats Hypertension 34 1999 914 919
23. K.B. Brosnihan, P. Li, J.P. Figueroa, D. Ganten, and C.M. Ferrario Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats Am J Physiol Heart Circ Physiol 294 2008 H1995 2001
24. B. Halliwell Biochemistry of oxidative stress Biochem Soc Trans 35 2007 1147 1150
25. J.G. Wilcox, J. Hwang, H.N. Hodis, A. Sevanian, and R.A. Lobo Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low density lipoproteins Fertil Steril 67 1997 57 62
26. B.R. Bhavnani, A. Cecutti, A. Gerulath, A.C. Woolever, and M. Berco Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women Menopause 8 2001 408 419
27. A. Wakatsuki, N. Ikenoue, K. Shinohara, K. Watanabe, and T. Fukaya Small low-density lipoprotein particles and endothelium-dependent vasodilation in postmenopausal women Atherosclerosis 177 2004 329 336
28. V. Ralevic Purines as neurotransmitters and neuromodulators in blood vessels Curr Vasc Pharmacol 7 2009 3 14
29. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 2004 1701 1712
30. L. Novensà, S. Novella, P. Medina, G. Segarra, N. Castillo, and M. Heras Aging negatively affects estrogens-mediated effects on nitric oxide bioavailability by shifting ERα/ERβ balance in female mice PLoS One 6 2011 e25335
31. J. Yeboah, K. Klein, B. Brosnihan, D. Reboussin, and D.M. Herrington Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease Menopause 15 2008 1060 1064
32. A.C. Montezano, and R.M. Touyz Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases Basic Clin Pharmacol Toxicol 110 2012 87 94
33. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997;20:II-26-33.
34. K.L. Chambliss, and P.W. Shaul Estrogen modulation of endothelial nitric oxide synthase Endocr Rev 23 2002 665 686
35. L. Novensa, J. Selent, M. Pastor, K. Sandberg, M. Heras, and A.P. Dantas Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17{beta}-estradiol Hypertension 56 2010 405 411
36. H. Kuhl Pharmacology of estrogens and progestogens: influence of different routes of administration Climacteric 8 Suppl 1 2005 3 63
37. K.L. Edlefsen, R.D. Jackson, and R.L. Prentice The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women Menopause 17 2010 622 629
38. C. Kornhauser, J.M. Malacara, M.E. Garay, and E.L. Perez-Luque The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension J Hum Hypertens 11 1997 405 411
39. P.J. Harvey, D. Molloy, J. Upton, and L.M. Wing Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension Blood Press 9 2000 275 282
40. L.A. Fortepiani, H. Zhang, L. Racusen, L.J. Roberts 2nd, and J.F. Reckelhoff Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rats Hypertension 41 2003 640 645
41. H.G. Bohlen Localization of vascular resistance changes during hypertension Hypertension 8 1986 181 183